Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flemming Bendtsen

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
JHEP Reports : Innovation in Hepatology|January 29, 2024
Low sphingolipid levels predict poor survival in patients with alcohol-related liver diseaseThit Mynster Kronborg, Qian Gao, Kajetan Trošt, et al.
Journal of Hepatology|February 2, 2016
Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patientsJonel Trebicka, Matthias von Heydebrand, Jennifer Lehmann, et al.
Journal of Gastroenterology and Hepatology|July 4, 2017
Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trialNina Kimer, Julie S Pedersen, Juliette Tavenier, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosisDaniel Markwardt, Lesca Holdt, Christian Steib, et al.
The American Journal of Gastroenterology|August 20, 2024
Spine and Sacroiliac Joint Involvement in Newly Diagnosed Patients With Inflammatory Bowel Disease: Clinical and MRI Findings From a Population-Based CohortNora Vladimirova, Jakob Møller, Mohamed Attauabi, et al.
Gastroenterology|May 4, 2015
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver DiseasePaul Angulo, David E Kleiner, Sanne Dam-Larsen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2014
Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertensionJonel Trebicka, Cyrus Wix, Matthias von Heydebrand, et al.
BMC Gastroenterology|January 23, 2024
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver diseaseMira Thing, Mikkel Parsberg Werge, Nina Kimer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2019
Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosisJennifer Lehmann, Michael Praktiknjo, Mette Juul Nielsen, et al.
Scientific Reports|August 5, 2022
Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitisRikard G Fred, Julie Steen Pedersen, Jonatan J Thompson, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
JHEP Reports : Innovation in Hepatology|January 29, 2024
Low sphingolipid levels predict poor survival in patients with alcohol-related liver diseaseThit Mynster Kronborg, Qian Gao, Kajetan Trošt, et al.
Journal of Hepatology|February 2, 2016
Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patientsJonel Trebicka, Matthias von Heydebrand, Jennifer Lehmann, et al.
Journal of Gastroenterology and Hepatology|July 4, 2017
Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trialNina Kimer, Julie S Pedersen, Juliette Tavenier, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosisDaniel Markwardt, Lesca Holdt, Christian Steib, et al.
The American Journal of Gastroenterology|August 20, 2024
Spine and Sacroiliac Joint Involvement in Newly Diagnosed Patients With Inflammatory Bowel Disease: Clinical and MRI Findings From a Population-Based CohortNora Vladimirova, Jakob Møller, Mohamed Attauabi, et al.
Gastroenterology|May 4, 2015
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver DiseasePaul Angulo, David E Kleiner, Sanne Dam-Larsen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2014
Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertensionJonel Trebicka, Cyrus Wix, Matthias von Heydebrand, et al.
BMC Gastroenterology|January 23, 2024
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver diseaseMira Thing, Mikkel Parsberg Werge, Nina Kimer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2019
Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosisJennifer Lehmann, Michael Praktiknjo, Mette Juul Nielsen, et al.
Scientific Reports|August 5, 2022
Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitisRikard G Fred, Julie Steen Pedersen, Jonatan J Thompson, et al.
Pageof 26